Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 RA, helps people ...
Organized labor has made inroads with the nursing profession in recent years, and a Medscape survey learned that about 1 in 7 ...
Data from a new mouse model may help advance therapeutic development in celiac disease, including improved TG2 inhibitors and ...
Advances in robotics, imaging, and data integration are enabling more individualised knee prosthesis positioning, raising ...
A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...
A real-world analysis reveals that tildrakizumab is highly effective and safe in patients with moderate-to-severe plaque ...
Reductions in BMI and A1c levels during intentional weight loss are linked to fewer microvascular and macrovascular ...
Teenagers and young adults who use pre-workout dietary supplements to boost exercise performance and energy are likely to get ...
Adding romosozumab to ongoing denosumab treatment shows increased lumbar spine bone mineral density with preserved anabolic ...
Founded in 2021, Blue Circle Health provides a variety of medical, educational, psychological, and financial services over a ...
A large-scale analysis suggests that the gut microbiome can be modulated by diet with both favorable and unfavorable effects ...
A growing body of evidence suggests GLP-1 receptor agonists may improve survival as well as reduce chemotherapy-related toxicities in women with breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results